Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | AGTR1 | P30556 | 5/20 | 0.44 |
| ▸ | AGTR2 | P50052 | 5/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9708456 | 0.95 | AGTR1 (0.50) | AGTR1AGTR2 | |
| SCHEMBL9708754 | 0.94 | AGTR1 (0.48) | TSHRHSD17B10ALDH1A1AGTR1AGTR2 | |
| SCHEMBL9708268 | 0.94 | TSHR (0.46) | TSHRHSD17B10ALOX15ALDH1A1TP53 | |
| SCHEMBL9707374 | 0.94 | AGTR1 (0.46) | HSD17B10ALOX15AGTR1AGTR2 | |
| SCHEMBL9708739 | 0.94 | TSHR (0.45) | TSHRHSD17B10ALOX15ALDH1A1TP53 | |
| SCHEMBL9708013 | 0.94 | ADORA3 (0.44) | AGTR1AGTR2 | |
| SCHEMBL9708134 | 0.94 | ADORA1 (0.49) | AGTR1AGTR2 | |
| SCHEMBL9707867 | 0.94 | ADORA3 (0.44) | AGTR1AGTR2 | |
| SCHEMBL9708848 | 0.93 | ADORA1 (0.48) | AGTR1AGTR2 | |
| SCHEMBL9708564 | 0.93 | AGTR1 (0.46) | HSD17B10ALOX15AGTR1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1992007852-A1 | BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1992-05-14 | — | — | WO | disclosed |